Login / Signup

Cost-Effectiveness Analysis of Metronidazole versus Metronidazole with Diloxanide Furoate in the Treatment of Amoebiasis in Ethiopia.

Nanati LegeseTemesgen Aferu YilmaTsehay Kassa
Published in: ClinicoEconomics and outcomes research : CEOR (2021)
This study revealed the addition of diloxanide to standard treatment to be a more effective and more costly treatment strategy. Therefore, a decision for choosing the medication should be based on the ability of patients to pay for the treatment.
Keyphrases
  • healthcare
  • end stage renal disease
  • combination therapy
  • peritoneal dialysis
  • health insurance
  • single cell
  • electronic health record
  • adverse drug
  • patient reported